Table 1.

Characteristics of patients with extramedullary tumor tissue sequenced in the study cohort

SampleNew IDAge at EMD, ySexSites of diseaseSite of biopsyDe novo
EMD 
EMD at relapse Visceral disease BM FISH at DXR-ISS at DXOS from EMD, yStatus at last FU
EMD EMD1 52.4 Soft tissue, multiple sites Lymph node   Monosomy 1, 8, 13, 14, 17 II 3.3 Deceased 
EMD EMD2 46.2 Pelvic mass Pelvic mass   t(14;16), gain 1q, del 13q 10.8 Deceased 
EMD EMD3 65.6 Adrenal, RP soft tissue RP soft tissue  HD, del 13q III 1.2 Deceased 
EMD EMD4 63.9 Liver Liver  HD II 0.1 Deceased 
EMD EMD5 63.7 Soft tissue, skin Soft tissue   HD III 3.8 Alive 
EMD EMD6 69.7 Abdominal soft tissue Soft tissue   HD, Gain 1q, del1p II 3.5 Alive 
EMD EMD7 70.3 Soft tissue, perinephric Soft tissue   t(11;14) II 0.6 Deceased 
EMD EMD8 57.1 Sacral mass, chest wall Chest wall   t(4;14), del13q III 4.2 Alive 
EMD EMD9 72.2 Liver, pancreas Liver  HD II 0.4 Deceased 
EMD EMD10 71.6 Soft tissue Soft tissue   NA NA 2.1 Deceased 
EMD EMD11 81.8 Inguinal soft tissue Soft tissue   t(4;14) II 1.4 Deceased 
EMD EMD12 86 Chest wall, thyroid Soft tissue  HD III 0.3 Deceased 
EMD + BM EMD13 77.8 Pleura, orbit Pleura  t(11;14); del13q 1.4 Deceased 
EMD + BM EMD14 61.9 Lymph node, soft tissue, kidney, and central nervous system Soft tissue  HD NA 0.5 Deceased 
EMD + BM EMD15 65.6 Lymph node Lymph node   NA NA 3.5 Alive 
EMD + BM EMD16 53.7 Breast Breast   t(4;14), gain 1q II 0.5 Deceased 
EMD + BM EMD17 52.4 Pancreas Pancreas  HD, Amp 1q II 0.6 Alive 
EMD + BM EMD18 62.2 Lung Lung  Monosomy 13, 14 6.4 Deceased 
SampleNew IDAge at EMD, ySexSites of diseaseSite of biopsyDe novo
EMD 
EMD at relapse Visceral disease BM FISH at DXR-ISS at DXOS from EMD, yStatus at last FU
EMD EMD1 52.4 Soft tissue, multiple sites Lymph node   Monosomy 1, 8, 13, 14, 17 II 3.3 Deceased 
EMD EMD2 46.2 Pelvic mass Pelvic mass   t(14;16), gain 1q, del 13q 10.8 Deceased 
EMD EMD3 65.6 Adrenal, RP soft tissue RP soft tissue  HD, del 13q III 1.2 Deceased 
EMD EMD4 63.9 Liver Liver  HD II 0.1 Deceased 
EMD EMD5 63.7 Soft tissue, skin Soft tissue   HD III 3.8 Alive 
EMD EMD6 69.7 Abdominal soft tissue Soft tissue   HD, Gain 1q, del1p II 3.5 Alive 
EMD EMD7 70.3 Soft tissue, perinephric Soft tissue   t(11;14) II 0.6 Deceased 
EMD EMD8 57.1 Sacral mass, chest wall Chest wall   t(4;14), del13q III 4.2 Alive 
EMD EMD9 72.2 Liver, pancreas Liver  HD II 0.4 Deceased 
EMD EMD10 71.6 Soft tissue Soft tissue   NA NA 2.1 Deceased 
EMD EMD11 81.8 Inguinal soft tissue Soft tissue   t(4;14) II 1.4 Deceased 
EMD EMD12 86 Chest wall, thyroid Soft tissue  HD III 0.3 Deceased 
EMD + BM EMD13 77.8 Pleura, orbit Pleura  t(11;14); del13q 1.4 Deceased 
EMD + BM EMD14 61.9 Lymph node, soft tissue, kidney, and central nervous system Soft tissue  HD NA 0.5 Deceased 
EMD + BM EMD15 65.6 Lymph node Lymph node   NA NA 3.5 Alive 
EMD + BM EMD16 53.7 Breast Breast   t(4;14), gain 1q II 0.5 Deceased 
EMD + BM EMD17 52.4 Pancreas Pancreas  HD, Amp 1q II 0.6 Alive 
EMD + BM EMD18 62.2 Lung Lung  Monosomy 13, 14 6.4 Deceased 

Amp, amplification; DX, diagnosis; F, female; FU, follow-up; HD, hyperdiploid; ID, identifier; M, male; NA, not available; OS, overall survival; R-ISS, revised International Staging System; RP, retroperitoneal.

X indicates data are present.

or Create an Account

Close Modal
Close Modal